Sun Pharma
By therapeutic area
| Therapeutic area | Premium | Deals |
|---|---|---|
| dermatology | ×0.79 | 6 |
By stage at signing
| Phase | Premium | Deals |
|---|---|---|
| phase 3 | ×0.89 | 5 |
Strategy profile
Based on 5 disclosed transactions, Sun Pharma concentrates its licensing activity in Dermatology, Oncology, and WomensHealth. Sun Pharma pays a 0.79x discount to market median, with the strongest premiums in Dermatology (0.79x). Their most common deal structure is Acquisition, with an average disclosed value of $2.7B. Most recent activity: 2026.
Premium by therapeutic area
How Sun Pharma pays relative to peer medians in each TA
Pipeline coverage & gaps
Sun Pharma has disclosed activity in 1 of 12 tracked therapeutic areas. Gaps may represent whitespace opportunities for licensors.
Deal type breakdown
How this buyer structures its transactions
| Deal type | Count | Avg upfront | Avg total value |
|---|---|---|---|
| AcquisitionPrimary | 4 | $4.3B | $3.3B |
| License | 1 | $45M | $250M |
Recent disclosed deals
| Year | Asset | Licensor | Indication | Phase | Upfront | Total |
|---|---|---|---|---|---|---|
| 2026 | Checkpoint oncology assets | Checkpoint Therapeutics | oncology | unknown | — | $355M |
| 2026 | Organon (full company) | Organon | women's health | approved | $11.8B | $11.8B |
| 2025 | deuterated JAK inhibitor | Concert Pharmaceuticals | alopecia areata | phase_3 | $576M | $576M |
| 2023 | alopeciaAreata | Concert Pharmaceuticals | alopeciaAreata | phase_3 | $576M | $576M |
| 2022 | acne | Nuvation Bio | acne | phase_1 | $45M | $250M |
How this is computed
For each Sun Pharma deal we find the median total deal value of comparable transactions (same therapeutic area + phase, falling back to TA-only with ≥3 peers). The buyer’s deal divided by the peer median is the per-deal premium. We trim outliers, take the trimmed mean, and clamp to [0.7×, 1.5×] to reject data errors. Confidence scales with sample size.
Trimmed mean of 6 disclosed deal premiums vs. peer medians. Raw premium 0.785, clamped to [0.7, 1.5].